Published in
American Heart Association, Circulation, 5(141), p. 407-410, 2020
DOI: 10.1161/circulationaha.119.044359
Links
Tools
Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%
Journal article published in 2020 by
Christopher P. Cannon,
Vlado Perkovic,
Rajiv Agarwal,
James Baldassarre,
George Bakris,
David M. Charytan 
,
Dick de Zeeuw,
Robert Edwards,
Tom Greene,
Hiddo J. L. Heerspink,
Meg J. Jardine,
Adeera Levin,
Jing-Wei Li,
Bruce Neal,
Carol Pollock
and other authors.
,
Dick de Zeeuw,
Robert Edwards,
Tom Greene,
Hiddo J. L. Heerspink,
Meg J. Jardine,
Adeera Levin,
Jing-Wei Li,
Bruce Neal,
Carol Pollock
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 